176 related articles for article (PubMed ID: 3092529)
1. Theophylline blunts the GH-response to growth hormone releasing hormone in normal subjects.
Losa M; Huss R; König A; Müller OA; von Werder K
Acta Endocrinol (Copenh); 1986 Aug; 112(4):473-80. PubMed ID: 3092529
[TBL] [Abstract][Full Text] [Related]
2. Effects of theophylline infusion on the growth hormone (GH) and prolactin response to GH-releasing hormone administration in acromegaly.
Losa M; Alba-Lopez J; Schopohl J; Sobiesczcyk S; Chiodini PG; Müller OA; von Werder K
J Endocrinol Invest; 1988 Oct; 11(9):663-7. PubMed ID: 3146595
[TBL] [Abstract][Full Text] [Related]
3. Restoration of normal growth hormone responsiveness to GHRH in normal aged men by infusion of low amounts of theophylline.
Coiro V; Volpi R; Cavazzini U; Bertoni P; Corradi A; Bianconi L; Davoli C; Rossi G; Chiodera P
J Gerontol; 1991 Sep; 46(5):M155-8. PubMed ID: 1890280
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
Massoud AF; Hindmarsh PC; Brook CG
Clin Endocrinol (Oxf); 1997 Nov; 47(5):537-47. PubMed ID: 9425393
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone-releasing hormone infusion in patients with active acromegaly.
Losa M; Chiodini PG; Liuzzi A; König A; Müller OA; Schopohl J; von Werder K
J Clin Endocrinol Metab; 1986 Jul; 63(1):88-93. PubMed ID: 3086362
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone releasing factor infusion does not sustain elevated GH-levels in normal subjects.
Losa M; Bock L; Schopohl J; Stalla GK; Müller OA; von Werder K
Acta Endocrinol (Copenh); 1984 Dec; 107(4):462-70. PubMed ID: 6440392
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a limited growth hormone (GH)-releasing hormone (GHRH)-releasable quantity of GH: effects of 6-hour infusions of GHRH on GH secretion in normal man.
Vance ML; Kaiser DL; Evans WS; Thorner MO; Furlanetto R; Rivier J; Vale W; Perisutti G; Frohman LA
J Clin Endocrinol Metab; 1985 Feb; 60(2):370-5. PubMed ID: 3917460
[TBL] [Abstract][Full Text] [Related]
8. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
[TBL] [Abstract][Full Text] [Related]
9. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.
Arvat E; Gianotti L; Grottoli S; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1994 Nov; 79(5):1440-3. PubMed ID: 7962341
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone (GH) rebound rise following somatostatin infusion withdrawal: studies in dogs with the use of GH-releasing hormone and a GH-releasing peptide.
Rigamonti AE; Cavallera G; Bonomo S; Deghenghi R; Locatelli V; Cella SG; Müller EE
Eur J Endocrinol; 2001 Nov; 145(5):635-44. PubMed ID: 11720883
[TBL] [Abstract][Full Text] [Related]
11. Galanin reinstates the growth hormone response to repeated growth hormone-releasing hormone administration in man.
Arvat E; Ghigo E; Nicolosi M; Boffano GM; Bellone J; Yin-Zhang W; Mazza E; Camanni F
Clin Endocrinol (Oxf); 1992 Apr; 36(4):347-50. PubMed ID: 1385023
[TBL] [Abstract][Full Text] [Related]
12. Galanin infusion partially restores the blunted growth hormone responses to repeated growth hormone releasing hormone stimuli in normal adults.
Sartorio A; Spada A; Conti A; Grugni G; Morabito F; Faglia G
J Endocrinol Invest; 1993 Feb; 16(2):95-8. PubMed ID: 7681861
[TBL] [Abstract][Full Text] [Related]
13. Dual effects of growth hormone (GH)-releasing hormone infusion in normal men: somatotroph desensitization and increase in releasable GH.
Vance ML; Kaiser DL; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1986 Mar; 62(3):591-4. PubMed ID: 3080467
[TBL] [Abstract][Full Text] [Related]
14. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
[TBL] [Abstract][Full Text] [Related]
15. The effect of pulsatile administration, continuous infusion, and diurnal variation on the growth hormone (GH) response to GH-releasing hormone in normal men.
Hulse JA; Rosenthal SM; Cuttler L; Kaplan SL; Grumbach MM
J Clin Endocrinol Metab; 1986 Oct; 63(4):872-8. PubMed ID: 3091629
[TBL] [Abstract][Full Text] [Related]
16. Short term continuous intravenous infusion of growth hormone (GH) inhibits GH-releasing hormone-induced GH secretion: a time-dependent effect.
Rosenthal SM; Kaplan SL; Grumbach MM
J Clin Endocrinol Metab; 1989 Jun; 68(6):1101-5. PubMed ID: 2498383
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone responses to continuous infusions of growth hormone-releasing hormone.
Gelato MC; Rittmaster RS; Pescovitz OH; Nicoletti MC; Nixon WE; D'Agata R; Loriaux DL; Merriam GR
J Clin Endocrinol Metab; 1985 Aug; 61(2):223-8. PubMed ID: 3924946
[TBL] [Abstract][Full Text] [Related]
18. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.
Alba-Roth J; Müller OA; Schopohl J; von Werder K
J Clin Endocrinol Metab; 1988 Dec; 67(6):1186-9. PubMed ID: 2903866
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
Losa M; Schopohl J; König A; Müller OA; von Werder K
J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
[TBL] [Abstract][Full Text] [Related]
20. Intravenous refeeding blocks growth hormone (GH)-provoked rises in serum free fatty acids and blunting of somatotroph response to GH-releasing hormone in normal men.
Rosenbaum M; Fong YM; Hesse DG; Tracey KJ; Hintz RL; Lowry SF; Gertner JM
J Clin Endocrinol Metab; 1989 Aug; 69(2):310-6. PubMed ID: 2502553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
